Papulopustular lesions of the face caused by panitumumab: case report and literature review
Introduction: Panitumumab (VECTIBIX®) is a monoclonal antibody used alone or in combination with a chemotherapy for management of metastatic colorectal cancer. Observation: A patient treated with this protocol manifested skin lesions; the etiological diagnosis was difficult. The lesions, namely a pa...
Saved in:
Main Authors: | Ravasco Jonathan (Author), Lebaud Philippe (Author), Bodin Hélène (Author) |
---|---|
Format: | Book |
Published: |
EDP Sciences,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRIDE syndrome associated with panitumumab treatment - case report and literature review
by: Magalena Pałdyna, et al.
Published: (2023) -
Panitumumab-Induced Periorbital Dermatitis: A Case Report
by: Pongbangpho N, et al.
Published: (2024) -
Papulopustular and Ocular Rosacea with an Alleged Coincidence of Cutaneous Lupus Erythematosus: A Case Report
by: Irma Bernadette S. Sitohang, et al.
Published: (2021) -
Papulopustular infantile acne treated with oral isotretinoin
by: Grasielle Silva Santos, et al.
Published: (2023) -
Papulopustular Facial Eruption in a Child: A Quiz
by: Louise Parke, et al.
Published: (2019)